Nephros (NEPH) EBIT Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Nephros | 38.93 Mn | 34.91 Mn | 2.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.94% |
| Dec 31, 2025 | 15.16% |
| Sep 30, 2025 | 18.50% |
| Jun 30, 2025 | 16.60% |
| Mar 31, 2025 | 20.60% |
| Dec 31, 2024 | 25.31% |
| Sep 30, 2024 | 18.09% |
| Jun 30, 2024 | 18.25% |
| Mar 31, 2024 | 31.24% |
| Dec 31, 2023 | 2.30% |
| Sep 30, 2023 | 16.86% |
| Jun 30, 2023 | 7.80% |
| Mar 31, 2023 | 22.90% |
| Dec 31, 2022 | -11.45% |
| Sep 30, 2022 | -19.85% |
| Jun 30, 2022 | -3.06% |
| Mar 31, 2022 | -20.66% |
| Dec 31, 2021 | -3.43% |
| Sep 30, 2021 | -4.71% |
| Jun 30, 2021 | -6.46% |
| Mar 31, 2021 | -4.78% |
| Dec 31, 2020 | 5.14% |
| Sep 30, 2020 | 3.03% |
| Jun 30, 2020 | -21.89% |
| Mar 31, 2020 | -4.95% |
| Dec 31, 2019 | 18.11% |
| Sep 30, 2019 | -0.41% |
| Jun 30, 2019 | -6.42% |
| Mar 31, 2019 | -18.28% |
| Dec 31, 2018 | 7.42% |
| Sep 30, 2018 | 3.42% |
| Jun 30, 2018 | -0.78% |
| Mar 31, 2018 | -2.18% |
| Dec 31, 2017 | 18.37% |
| Sep 30, 2017 | 9.49% |
| Jun 30, 2017 | 2.92% |
| Mar 31, 2017 | -1.70% |
| Dec 31, 2016 | 1.02% |
| Sep 30, 2016 | -8.43% |
| Jun 30, 2016 | -6.44% |
| Mar 31, 2016 | -4.53% |
| Dec 31, 2015 | -9.16% |
| Sep 30, 2015 | -22.57% |
| Jun 30, 2015 | -10.17% |